ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Pfizer is selling its pharmaceutical manufacturing plant in Nerviano, Italy, to Actavis, the Icelandic generic drug company. The plant, which employs around 340 people, specializes in the manufacture of oncology products. Actavis CEO Robert Wessman says the facility will help his company meet growth projections for its oncology portfolio. Separately, Actavis has entered a multiyear agreement with Pfizer for the supply of oncology products.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter